hydroxychloroquine has been researched along with Chondrocalcinosis in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Chondrocalcinosis: Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This report describes a 32-year-old woman presenting since childhood with progressive calcium pyrophosphate disease (CPPD), characterized by severe arthropathy and chondrocalcinosis involving multiple peripheral joints and intervertebral disks." | 3.78 | Novel ANKH amino terminus mutation (Pro5Ser) associated with early-onset calcium pyrophosphate disease with associated phosphaturia. ( Armas, JB; Brown, MA; Couto, AR; Finzel, K; Gruber, BL; Terkeltaub, RA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abhishek, A | 1 |
| Doherty, M | 1 |
| Gruber, BL | 1 |
| Couto, AR | 1 |
| Armas, JB | 1 |
| Brown, MA | 1 |
| Finzel, K | 1 |
| Terkeltaub, RA | 1 |
| Rothschild, B | 1 |
| Yakubov, LE | 1 |
1 review available for hydroxychloroquine and Chondrocalcinosis
| Article | Year |
|---|---|
Pathophysiology of articular chondrocalcinosis--role of ANKH.
Topics: Animals; Ankylosis; Calcium Pyrophosphate; Chondrocalcinosis; Crystallization; Humans; Hydroxychloro | 2011 |
2 trials available for hydroxychloroquine and Chondrocalcinosis
| Article | Year |
|---|---|
Varied regimens in RA and pseudogout evaluated.
Topics: Aged; Arthritis, Rheumatoid; Chondrocalcinosis; Clinical Trials as Topic; Colchicine; Drug Therapy, | 1980 |
Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chondrocalcinosis; Double-Blind Method; Female; Human | 1997 |
1 other study available for hydroxychloroquine and Chondrocalcinosis
| Article | Year |
|---|---|
Novel ANKH amino terminus mutation (Pro5Ser) associated with early-onset calcium pyrophosphate disease with associated phosphaturia.
Topics: Adult; Antirheumatic Agents; Calcium Pyrophosphate; Chondrocalcinosis; Drug Therapy, Combination; Fe | 2012 |